Advance Search
ZENG Yan, YANG Xiaoying, LI Jiao. Effects of pranoprofen combined with sodium hyaluronate on visual function, tear inflammatory factors and vision-related quality of life in adolescent patients with dry eye disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 33-36. DOI: 10.7619/jcmp.20211415
Citation: ZENG Yan, YANG Xiaoying, LI Jiao. Effects of pranoprofen combined with sodium hyaluronate on visual function, tear inflammatory factors and vision-related quality of life in adolescent patients with dry eye disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 33-36. DOI: 10.7619/jcmp.20211415
shu

Effects of pranoprofen combined with sodium hyaluronate on visual function, tear inflammatory factors and vision-related quality of life in adolescent patients with dry eye disease

  • Department of Ophthalmology, Affiliated Hospital of Panzhihua College, Panzhihua, Sichuan, 617000

More Information
  • Received Date: March 30, 2021
  • Available Online: November 15, 2021
  • Published Date: October 27, 2021
    Graphical Abstract
    • Abstract
  •   Objective  To explore the effects of pranoprofen combined with sodium hyaluronate on visual function, tear inflammatory factors and vision-related quality of life (VRQOL) in adolescent patients with dry eye disease (DED).
      Methods  A total of 100 DED patients were selected as research objects and divided into observation group (pralprofen combined with sodium hyaluronate, 50 cases) and control group (sodium hyaluronate alone, 50 cases) according to random number table method. Clinical efficacy, adverse reactions, visual function, tear inflammatory factor level and VRQOL score before and after treatment were compared between the two groups.
      Results  The total effective rate of the observation group was 90.00%, which was significantly higher than 74.00% of the control group (P < 0.05). After treatment, the levels of interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), interleukin-1 β (IL-1β) and tumor necrosis factor -α (TNF-α) in tears in the observation group were significantly lower than those in the control group, and VRQOL score was significantly higher than that in the control group (P < 0.05). There was no significant difference in subjective symptom score between the two groups (P>0.05).
      Conclusion  Pralprofen combined with sodium hyaluronate has significant efficacy in treatment of adolescents with DED, which can improve the visual function of adolescent patients, reduce the inflammatory response of tears, and improve the vision-related quality of life.
    • FullText(HTML)
    • References (21)
  • [1]
    O'NEIL E C, HENDERSON M, MASSARO-GIORDANO M, et al. Advances in dry eye disease treatment[J]. Curr Opin Ophthalmol, 2019, 30(3): 166-178. doi: 10.1097/ICU.0000000000000569
    [2]
    NADERI K, GORMLEY J, O'BRART D. Cataract surgery and dry eye disease: a review[J]. Eur J Ophthalmol, 2020, 30(5): 840-855. doi: 10.1177/1120672120929958
    [3]
    何星光, 龚兰兰, 余才翰. 玻璃酸钠对白内障超声乳化联合IOL植入术后眼部炎症反应和干眼症的影响[J]. 国际眼科杂志, 2018, 18(4): 697-701. https://www.cnki.com.cn/Article/CJFDTOTAL-GJYK201804030.htm
    [4]
    覃艮艳, 蒋鹏飞, 彭俊, 等. 普拉洛芬联合玻璃酸钠治疗干眼的临床观察[J]. 湖南中医药大学学报, 2020, 40(4): 490-493. doi: 10.3969/j.issn.1674-070X.2020.04.021
    [5]
    张彤, 吴杰, 李虎, 等. 妥布霉素地塞米松滴眼液联合普拉洛芬眼液对中老年白内障术后炎症因子水平的影响[J]. 中国老年学杂志, 2020, 40(8): 1685-1688. doi: 10.3969/j.issn.1005-9202.2020.08.036
    [6]
    申海静, 陈铁红. 玻璃酸钠联合环孢素A治疗混合型干眼症的疗效观察[J]. 国际眼科杂志, 2020, 20(6): 1031-1034. https://www.cnki.com.cn/Article/CJFDTOTAL-GJYK202006026.htm
    [7]
    杨茂俊, 梁岚, 罗康生, 等. 普拉洛芬联合玻璃酸钠治疗中重度干眼的短期疗效[J]. 国际眼科杂志, 2019, 19(9): 1570-1574. https://www.cnki.com.cn/Article/CJFDTOTAL-GJYK201909035.htm
    [8]
    赵静, 陈伟伟, 金忠平. 普拉洛芬联合0.3%玻璃酸钠滴眼液治疗白内障术后干眼症的疗效分析[J]. 中国基层医药, 2019, 26(24): 3011-3014. doi: 10.3760/cma.j.issn.1008-6706.2019.24.017
    [9]
    亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识: 定义和分类(2020年)[J]. 中华眼科杂志, 2020, 56(6): 418-422. doi: 10.3760/cma.j.cn112142-20200316-00190
    [10]
    RÆDER S, KLYVE P, UTHEIM T P. Tørre øyne-diagnostikk og behandling[J]. Tidsskriftet, 2019: 139(11).
    [11]
    MIDORIKAWA-INOMATA A, INOMATA T, NOJIRI S, et al. Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease[J]. BMJ Open, 2019, 9(11): e033940. doi: 10.1136/bmjopen-2019-033940
    [12]
    JELIN E, WISLØFF T, MOE M C, et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population[J]. Heal Qual Life Outcomes, 2019, 17(1): 140. doi: 10.1186/s12955-019-1203-0
    [13]
    ROUEN P A, WHITE M L. Dry eye disease: prevalence, assessment, and management[J]. Home Healthc Now, 2018, 36(2): 74-83. doi: 10.1097/NHH.0000000000000652
    [14]
    唐颖, 田甜, 葛红岩. 干眼症发病机制与发病因素的研究进展[J]. 医学综述, 2019, 25(11): 2196-2201. doi: 10.3969/j.issn.1006-2084.2019.11.022
    [15]
    GANESALINGAM K, ISMAIL S, SHERWIN T, et al. Molecular evidence for the role of inflammation in dry eye disease[J]. Clin Exp Optom, 2019, 102(5): 446-454. doi: 10.1111/cxo.12849
    [16]
    祝艳妮, 寇张峰, 樊伟军, 等. 普拉洛芬滴眼液联合芪明颗粒对青少年LASIK术后干眼症泪膜稳定性和眼表功能的影响[J]. 现代中西医结合杂志, 2018, 27(24): 2688-2690. doi: 10.3969/j.issn.1008-8849.2018.24.020
    [17]
    BAUDOUIN C, IRKEÇ M, MESSMER E M, et al. Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting[J]. Acta Ophthalmol, 2018, 96(2): 111-119. doi: 10.1111/aos.13436
    [18]
    REYES J L, VANNAN D T, EKSTEEN B, et al. Innate and adaptive cell populations driving inflammation in dry eye disease[J]. Mediators Inflamm, 2018, 2018: 1-12.
    [19]
    姚贤凤, 王利民, 陈梅. 疏肝健脾法联合中药电离子透入对青年干眼患者视功能、泪液分泌和泪液中IL-1β、TNF-α表达的影响[J]. 眼科新进展, 2019, 39(2): 149-152. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201902014.htm
    [20]
    赵蒙蒙, 金兰, 宋艳敏, 等. 杞菊地黄丸联合中药熏蒸对干眼症患者OSDI评分、溶菌酶水平及视功能评分的影响[J]. 海南医学, 2019, 30(22): 2947-2950. doi: 10.3969/j.issn.1003-6350.2019.22.027
    [21]
    祁盈. 升阳养血汤联合玻璃酸钠治疗对39例干眼病患者泪腺分泌及生存质量的影响[J]. 实用中西医结合临床, 2020, 20(18): 54-55, 116. https://www.cnki.com.cn/Article/CJFDTOTAL-SZXL202018026.htm
    • Related Articles

  • Related Articles

    [1]GU Xin, JING Liwei, WANG Andi, LIU Jun, DAI Yongqiang, ZHANG Baoling. Analysis of the recurrence rate and risk factors of renal calculi after intracavitary lithotripsy[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 39-41. DOI: 10.7619/jcmp.20232864
    [2]LIU Haijia, CHEN Ming, LI Yanzhen. Analysis in risk factors of postoperative recurrence of patients with refractory epilepsy and establishment of a risk prediction model[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 7-11. DOI: 10.7619/jcmp.20240080
    [3]SHEN Bingyan, SHEN Qian, XU Lingling. Influence factors for recurrence of cytoreductive surgery in patients with epithelial ovarian cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(4): 14-18. DOI: 10.7619/jcmp.20231817
    [4]CHEN Chunyu, ZHOU Jing, LIU Guyue, YU Jie, GU Jiangkui. Construction and validation of a Nomogram model for postoperative early recurrence in patients with non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2023, 27(24): 7-13. DOI: 10.7619/jcmp.20232467
    [5]XUE Huimin, CHEN Tao, ZHU Xiaojun. Analysis of postoperative recurrence and risk factors of patients with liver cancer after radical resection[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 35-38. DOI: 10.7619/jcmp.20221356
    [6]GENG Suhong, WANG Weina, WANG Xiaona. Efficacy of rituximab combined with conventional chemotherapy in treating patients with diffuse large B-cell lymphoma and influencing factors of recurrence[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 93-97. DOI: 10.7619/jcmp.20213295
    [7]DONG Yanping, WANG Jiemin, WANG Yujin, REN Yali, DONG Yucheng, YONG Yanjun, SU Xuandi, WANG Jixiang, SU Nan, WANG Fuli, XIA Duosheng. Construction and evaluation of Nomogram prediction model for postoperative recurrence of pterygium[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 52-56. DOI: 10.7619/jcmp.20214610
    [8]LING Yan. Nutritional risk and its influencing factors of severe neurosurgical patients[J]. Journal of Clinical Medicine in Practice, 2017, (10): 43-46. DOI: 10.7619/jcmp.201710014
    [9]YU Shuying. The effect of risk factors management nursing in reducing infection in operation room[J]. Journal of Clinical Medicine in Practice, 2015, (14): 93-95,109. DOI: 10.7619/jcmp.201514030
    [10]CHEN Jinghua, TANG Hui, YU Chuanhu, LI Wei. Research on recurrent situation and risk factors of endometrial cancer[J]. Journal of Clinical Medicine in Practice, 2013, (13): 145-147. DOI: 10.7619/jcmp.201313053

  • Cited by

    Periodical cited type(4)

    1. 殷华芳，沙莎，蔡依玲，于波，刘佳，何佳，孙玲娣，王坚. 宫颈癌放射治疗相关卵巢损伤的分子机制及防治策略研究进展. 实用临床医药杂志. 2024(10): 141-144 . 本站查看
    2. 张玉洲，李晓敏，孙少霖. 蓝萼乙素通过Akt/BAD通路对宫颈癌裸鼠移植瘤生长的影响. 现代药物与临床. 2024(06): 1384-1389 .
    3. 沈静，张丽华，徐晶晶，吕萌萌，吴东辰. 卡瑞利珠单抗联合白蛋白结合型紫杉醇对晚期宫颈癌患者肿瘤标志物、免疫功能和血管新生指标的影响. 现代生物医学进展. 2024(13): 2592-2595 .
    4. 曾美男. 早期宫颈癌术后不同治疗方法的临床效果分析. 实用妇科内分泌电子杂志. 2023(24): 28-30+85 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (386) PDF downloads (16) Cited by(4)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return